176
Views
1
CrossRef citations to date
0
Altmetric
Articles

Virtual high-throughput screening: potential inhibitors for the mycobacterial α-subunit of tryptophan synthase

, , , , &
Pages 342-353 | Received 02 Sep 2021, Accepted 23 Nov 2021, Published online: 08 Feb 2022

References

  • Delogu G, Sali M, Fadda G. The biology of Mycobacterium tuberculosis infection. Mediterr J Hematol Infect Dis. 2013;5:e2013070.
  • World Health Organization. Global tuberculosis report 2016; 2016.
  • Cruz A, Fraga AG, Fountain JJ, et al. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med. 2010;207:1609–1616.
  • Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev. 2003;16:463–496.
  • Tomioka H, Namba K. Development of antituberculous drugs: current status and future prospects. Kekkaku [Tuberculosis]. 2006;81:753–774.
  • WHO. Global tuberculosis report 2017; 2017.
  • Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis. 2004;8:392–402.
  • Lott JS. The tryptophan biosynthetic pathway is essential for Mycobacterium tuberculosis to cause disease. Biochem Soc Trans. 2020;48:2029–2037.
  • Umbreit WW, Wood WA, Gunsalus IC. The activity of pyridoxal phosphate in tryptopbane formation by cell-free enzyme preparations. J Biol Chem. 1946;165:731–732.
  • Consalvi S, Scarpecci C, Biava M, et al. Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development? Bioorg Med Chem Lett. 2019;29:126731.
  • Casino P, Niks D, Ngo H, et al. Allosteric regulation of tryptophan synthase channeling: the internal aldimine probed by trans-3-indole-3’-acrylate binding. Biochemistry. 2007;46:7728–7739.
  • Sachpatzidis A, Dealwis C, Lubetsky JB, et al. Crystallographic studies of phosphonate-based alpha-reaction transition-state analogues complexed to tryptophan synthase. Biochemistry. 1999;38:12665–12674.
  • Chang CA, Huang YM, Mueller LJ, et al. Investigation of structural dynamics of enzymes and protonation states of substrates using computational tools. Catalysts. 2016;6.
  • Abrahams KA, Cox JAG, Fütterer K, et al. Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface. Sci Rep. 2017;7:9430.
  • Ngo H, Harris R, Kimmich N, et al. Synthesis and characterization of allosteric probes of substrate channeling in the tryptophan synthase bienzyme complex. Biochemistry. 2007;46:7713–7727.
  • Bahar I, Jernigan RL. Cooperative fluctuations and subunit communication in tryptophan synthase. Biochemistry. 1999;38:3478–3490.
  • Zhang YJ, Reddy MC, Ioerger TR, et al. Tryptophan biosynthesis protects mycobacteria from CD4T-cell-mediated killing. Cell. 2013;155:1296–1308.
  • Brzović PS, Sawa Y, Hyde CC, et al. Evidence that mutations in a loop region of the alpha-subunit inhibit the transition from an open to a closed conformation in the tryptophan synthase bienzyme complex. J Biol Chem. 1992;267:13028–13038.
  • Hilario E, Caulkins BG, Huang Y-MM, et al. Visualizing the tunnel in tryptophan synthase with crystallography: insights into a selective filter for accommodating indole and rejecting water. Biochim Biophys Acta. 2016;1864:268–279.
  • Naz S, Farooq U, Ali S, et al. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations. J Biomol Struct Dyn. 2019;37:1043–1053.
  • Jade D, Ayyamperumal S, Tallapaneni V, et al. Virtual high throughput screening: potential inhibitors for SARS-CoV-2 PLPRO and 3CLPRO proteases. Eur J Pharmacol. 2021 Jun 15;901:174082.
  • Koushki EH, Abolghasemi S, Mollica A, et al. Structure-based virtual screening, molecular docking and dynamics studies of natural product and classical inhibitors against human dihydrofolate reductase. Netw Model Anal Health Inf Bioinforma. 2020;9:49.
  • UniProt Consortium. Uniprot: the universal protein knowledgebase. Nucleic Acids Res. 2018;46:2699–2699.
  • Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Bioinform. 2016;54:5.6.1–5.6.37.
  • Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci Publ Protein Soc. 1993;2:1511–1519.
  • Laskowski RA, MacArthur MW, Moss DS, et al. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr. 1993;26:283–291.
  • Le Guilloux V, Schmidtke P, Tuffery P. Fpocket: an open source platform for ligand pocket detection. BMC Bioinform. 2009;10:168.
  • Dias MV, Canduri F, da Silveira NJ, et al. Molecular models of tryptophan synthase from Mycobacterium tuberculosis complexed with inhibitors. Cell Biochem Biophys. 2006;44:375–384.
  • Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30:2785–2791.
  • Sadowski J, Gasteiger J, Klebe G. Comparison of automatic three-dimensional model builders using 639 X-ray structures. J Chem Inf Comp Sci. 1994;34:1000–1008.
  • Jones G, Willett P, Glen RC, et al. Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 1997;267:727–748.
  • Benet LZ, Hosey CM, Ursu O, et al. BDDCS, the rule of 5 and drugability. Adv Drug Deliv Rev. 2016;101:89–98.
  • Veber DF, Johnson SR, Cheng H-Y, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45:2615–2623.
  • Kumar R, Jade D, Gupta D. A novel identification approach for discovery of 5-HydroxyTriptamine 2A antagonists: combination of 2D/3D similarity screening, molecular docking and molecular dynamics. J Biomol Struct Dyn. 2019;37:931–943.
  • Sharma R, Jade D, Mohan S, et al. In-silico virtual screening for identification of potent inhibitor for L2-β-lactamase from Stenotrophomonas maltophilia through molecular docking, molecular dynamics analysis study. J Biomol Struct Dyn. 2021;39:7123–7137.
  • Wang J, Wang W, Kollman PA, et al. Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model. 2006;25:247–260.
  • Salentin S, Schreiber S, Haupt VJ, et al. PLIP: fully automated protein-ligand interaction profiler. Nucleic Acids Res. 2015;43:W443–W447.
  • Baell JB, Holloway GA. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem. 2010;53:2719–2740.
  • Pronk S, Páll S, Schulz R, et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics. 2013;29:845–854.
  • Huang W, Lin Z, van Gunsteren WF. Validation of the GROMOS 54A7 force field with respect to β-peptide folding. J Chem Theory Comput. 2011;7:1237–1243.
  • Schüttelkopf AW, van Aalten DM. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr. 2004;60:1355–1363.
  • Kumari R, Kumar R, Lynn A. G_mmpbsa – a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model. 2014;54:1951–1962.
  • Pandey P, Srivastava R, Bandyopadhyay P. Comparison of molecular mechanics-Poisson-Boltzmann surface area (MM-PBSA) and molecular mechanics-three-dimensional reference interaction site model (MM-3D-RISM) method to calculate the binding free energy of protein-ligand complexes: effect of metal ion and advance statistical test. Chem Phys Lett. 2018;695:69–78.
  • Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10:449–461.
  • Larkin MA, Blackshields G, Brown NP, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23:2947–2948.
  • Dunn MF, Aguilar V, Brzovic P, et al. The tryptophan synthase bienzyme complex transfers indole between the.alpha.- and.beta.-sites via a 25-30.ANG. long tunnel. Biochemistry. 1990;29:8598–8607.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.